McKesson weakness a buying opportunity, says Cowen Cowen recommends investors buy the weakness on McKesson (MCK) following Q3 results. The firm cited two one-time charges that hurt the quarter, the addition to its stock buyback authorization, and the acquisition of PSS World Medical (PSSI) which should help drive growth next year. Shares are Outperform rated.
News For MCK;PSSI From The Last 14 Days
Check below for free stories on MCK;PSSI the last two weeks.